Company
Vanquish Oncology
Vanquish Oncology, Inc. is a drug development company focused on targeting molecular defects in specific cancer cells to create personalized oncology therapeutics for unmet or underserved cancer markets.
Also known as VANQUISH ONCOLOGY, INC.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- VANQUISH ONCOLOGY, INC.
Claim, correct or request removal
Record updated 28 September 2026
About
Vanquish Oncology Inc. is an exciting new drug development company focused on targeting unexploited molecular defects in cancer cells to create first in class, personalized therapeutics for unmet or underserved cancer markets.
Funding snapshot
- Total raised
- $6.9MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $500K2020-06-30
Funding rounds
- Round, 2020
- $500K2020-06-30, SEC form D sold, 1 investor
- Round, 2019
- $1M2019-06-19, SEC form D sold, 1 investor
- Round, 2016
- $1.1M2016-02-16, SEC form D sold, 2 investors
- Round, 2013
- $4.4M2013-03-18, SEC form D sold, 3 investors
Products
- Other
- PAC-1
Loading relationship preview